biowaiver for higher strength [Regulatives / Guidelines]

posted by wienui  – Germany/Oman, 2022-02-01 10:12 (756 d 23:58 ago) – Posting: # 22768
Views: 1,961

(edited by wienui on 2022-02-01 15:29)

Hi John,

❝ Based on the above, can I file a biowaiver for the higher strength test product so I don't have to run a PK BE study?

Are both strengths (low & high) follow the following EMA 5% & exceients rule?

Amount of API must be < 5% of tablet core weight, and
Amounts of excipients are same per strength, or
Only the amount of a filler is changed to account for changes in API weight.


Complete thread:

UA Flag
 Admin contact
22,912 posts in 4,806 threads, 1,636 registered users;
36 visitors (1 registered, 35 guests [including 7 identified bots]).
Forum time: 10:11 CET (Europe/Vienna)

Exploratory analysis: The art of finding a Rembrandt
in a Jackson Pollock.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz